Hookworm infection affects an estimated 1 billion people in the world. It is endemic worldwide, including much of Africa, Asia, South America and the southeastern United States. Primary infection involves penetration of the skin by soil dwelling infectious filariform larvae. Presence of the worm within the skin may lead to pruritus and rash persisting for several weeks. Hookworms have a complex life cycle that begins and ends in the small intestine. The worms typically are restricted to the small intestine and usually cause mild diarrhea. We report here an unusual presentation of a hookworm infection in an allogeneic stem cell transplant recipient.
Thirty one year-old white male with acute promyelocytic leukemia (APL) in third hematologic complete remission (CR), previously treated with liposomal all-trans-retinoic acid (ATRA) plus idarubicin, arsenic trioxide (ATO) and oral ATRA underwent an allogeneic SCT from his HLAidentical sibling at MD Anderson Cancer Center on August 1999. His immediate post transplant course was uneventful; however, he remained PCR-positive 4 months after his transplantation. His immunosuppression was withdrawn initially, followed by treatments with oral ATRA, donor lymphocyte infusion (DLI) and ATO in early 2000. He had a third hematologic relapse in June 2000 and was given gemtuzumab ozogamicin (GO) 9 mg/m 2 i.v. Subsequently, his condition was complicated with a bacterial meningitis requiring hospitalization and eventual recovery in July 2000. He was given a second dose of GO followed by second DLI in early September 2000 and he received third DLI (1 Â 10 8 CD3 þ cells) in early October 2000 owing to persistent molecular disease. The patient was admitted with a mild rash on his upper and lower extremities as well as the neck and a diarrhea of about a liter/day, six in frequency, that developed two weeks after his third DLI. Physical examination revealed a temperature of 38.51C and diffuse erythematous maculopapular rash on the upper and lower extremities as well as the neck (Figure 1 ). He has been on prophylaxis with trimethoprim/sulfamethoxazole, itraconazole and valacyclovir. CBC revealed mild anemia and thrombocytopenia with a normal differential. Renal and liver function tests including alkaline phosphatase were within the normal range. Although clinical findings were suggestive of GVHD of skin and gut, it was decided to hold off immunosuppression until he had a documented GVHD as he had a previous history of CNS infection and he needed graft-versus-leukemia effect owing to molecular disease. A skin biopsy and flexible sigmoidoscopy with biopsy were performed. Flexible sigmoidoscopy revealed mild distal colitis in the sigmoid colon with scattered erosions and a live parasite noted in the distal sigmoid colon, the head of which was in the mucosa (Figure 2) . It was removed, and the pathologic examination confirmed hookworm infection. Upon further questioning, the patient 
gave a history of walking in the soil bare foot and drinking well water in the countryside. A clinical decision was made to treat the patient as ancylostomiasis. He was given mebendazole for 7 days. Although the skin and colon biopsies were read out as GVHD, no systemic immunosuppression was given to the patient. His skin rash, thought to be due to his helminthic infection, was treated with topical steroid. His diarrhea resolved within a week of mebendazole treatment. All of his blood and stool cultures remained negative. A repeat colonoscopy a week later revealed small erosions in the rectosigmoid; no additional parasites were identified. A bone marrow aspiration and biopsy were consistent with hematologic CR. The patient was discharged and his residual macular rash gradually disappeared within 2 weeks from its onset on topical steroid. During his follow-up, the patient enrolled to PR1 vaccine study and received three doses of vaccine in November and December 2000. A repeat colonoscopy performed in January 2001 was normal. A bone marrow examination in February 2001 showed molecular remission with 100% donor chimerism. The patient stayed in molecular remission since then, with mild mucosal GVHD of mouth and eyes, responding well to the local measures.
Helminthic infections of the gastrointestinal tract have been shown to cause morbidity and mortality in stem cell transplant setting. Infections of trematode worms, Clonorchiasis and Schistosomiasis, have been shown to be predisposing factors for veno-occlusive disease of the liver after allogeneic transplantation.
1,2 Infections of nematode roundworms, Strongyloidiasis and Ascariasis, have been reported to cause infections in autologous and allogeneic transplant settings. [3] [4] [5] [6] Strongyloidiasis may be fatal after stem cell transplantation. 3, 4 However, there have been no reports of hookworm infection after stem cell transplantation despite worldwide endemia. To our knowledge, this case is the first report of hookworm infection of nematode family, ancylostomiasis, occurring in an allogeneic stem cell transplant recipient. Hookworms typically infect the small intestine; therefore, this case is also one of the very rare examples of hookworm infection on human colonic mucosa. 7 Its clinical presentation with skin rash and mild diarrhea conforms to the GVHD of skin and bowel. Although the skin and colon biopsies were reported as GVHD in our case, we believe that hookworm infection was the primary event that might have triggered a possible mild graft-versus-host reaction, as the patient's symptoms disappeared after treatment with mebendazole and he was given no systemic immunosuppression. Our experience is consistent with a report showing the protozoal infection of gastrointestinal tract (blastocystosis) coexisting with GVHD of bowel and that diarrhea ameliorated with appropriate treatment of infection. 8 We conclude that hookworm infection occurs in recipients of allogeneic transplantation and may clinically mimic graft-versus-host disease. 
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